LOIS M RAMONDETTA to Mifepristone
This is a "connection" page, showing publications LOIS M RAMONDETTA has written about Mifepristone.
Connection Strength
0.609
-
Phase 2 trial of mifepristone (RU-486) in advanced or recurrent endometrioid adenocarcinoma or low-grade endometrial stromal sarcoma. Cancer. 2009 May 01; 115(9):1867-74.
Score: 0.320
-
In vitro evaluation of the growth inhibition and apoptosis effect of mifepristone (RU486) in human Ishikawa and HEC1A endometrial cancer cell lines. Cancer Chemother Pharmacol. 2008 Aug; 62(3):483-9.
Score: 0.289